2023-11-022024-11-302024-11-30false15256362SPIKEX NEURAL TECHNOLOGIES LIMITED2025-10-2962012falseiso4217:GBPxbrli:pure152563622023-11-01152563622024-11-30152563622023-11-022024-11-30152563622023-10-31152563622023-11-01152563622023-11-012023-11-0115256362bus:SmallEntities2023-11-022024-11-3015256362bus:AuditExempt-NoAccountantsReport2023-11-022024-11-3015256362bus:FullAccounts2023-11-022024-11-3015256362bus:PrivateLimitedCompanyLtd2023-11-022024-11-3015256362core:WithinOneYear2024-11-3015256362core:AfterOneYear2024-11-3015256362core:WithinOneYear2023-11-0115256362core:AfterOneYear2023-11-0115256362core:ShareCapital2024-11-3015256362core:SharePremium2024-11-3015256362core:RevaluationReserve2024-11-3015256362core:OtherReservesSubtotal2024-11-3015256362core:RetainedEarningsAccumulatedLosses2024-11-3015256362core:ShareCapital2023-11-0115256362core:SharePremium2023-11-0115256362core:RevaluationReserve2023-11-0115256362core:OtherReservesSubtotal2023-11-0115256362core:RetainedEarningsAccumulatedLosses2023-11-0115256362core:LandBuildings2024-11-3015256362core:PlantMachinery2024-11-3015256362core:Vehicles2024-11-3015256362core:FurnitureFittings2024-11-3015256362core:OfficeEquipment2024-11-3015256362core:NetGoodwill2024-11-3015256362core:IntangibleAssetsOtherThanGoodwill2024-11-3015256362core:ListedExchangeTraded2024-11-3015256362core:UnlistedNon-exchangeTraded2024-11-3015256362core:LandBuildings2023-11-0115256362core:PlantMachinery2023-11-0115256362core:Vehicles2023-11-0115256362core:FurnitureFittings2023-11-0115256362core:OfficeEquipment2023-11-0115256362core:NetGoodwill2023-11-0115256362core:IntangibleAssetsOtherThanGoodwill2023-11-0115256362core:ListedExchangeTraded2023-11-0115256362core:UnlistedNon-exchangeTraded2023-11-0115256362core:LandBuildings2023-11-022024-11-3015256362core:PlantMachinery2023-11-022024-11-3015256362core:Vehicles2023-11-022024-11-3015256362core:FurnitureFittings2023-11-022024-11-3015256362core:OfficeEquipment2023-11-022024-11-3015256362core:NetGoodwill2023-11-022024-11-3015256362core:IntangibleAssetsOtherThanGoodwill2023-11-022024-11-3015256362core:ListedExchangeTraded2023-11-022024-11-3015256362core:UnlistedNon-exchangeTraded2023-11-022024-11-3015256362core:MoreThanFiveYears2023-11-022024-11-3015256362core:Non-currentFinancialInstruments2024-11-3015256362core:Non-currentFinancialInstruments2023-11-0115256362dpl:CostSales2023-11-022024-11-3015256362dpl:DistributionCosts2023-11-022024-11-3015256362core:LandBuildings2023-11-022024-11-3015256362core:PlantMachinery2023-11-022024-11-3015256362core:Vehicles2023-11-022024-11-3015256362core:FurnitureFittings2023-11-022024-11-3015256362core:OfficeEquipment2023-11-022024-11-3015256362dpl:AdministrativeExpenses2023-11-022024-11-3015256362core:NetGoodwill2023-11-022024-11-3015256362core:IntangibleAssetsOtherThanGoodwill2023-11-022024-11-3015256362dpl:GroupUndertakings2023-11-022024-11-3015256362dpl:ParticipatingInterests2023-11-022024-11-3015256362dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-022024-11-3015256362core:ListedExchangeTraded2023-11-022024-11-3015256362dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-022024-11-3015256362core:UnlistedNon-exchangeTraded2023-11-022024-11-3015256362dpl:CostSales2023-11-012023-11-0115256362dpl:DistributionCosts2023-11-012023-11-0115256362core:LandBuildings2023-11-012023-11-0115256362core:PlantMachinery2023-11-012023-11-0115256362core:Vehicles2023-11-012023-11-0115256362core:FurnitureFittings2023-11-012023-11-0115256362core:OfficeEquipment2023-11-012023-11-0115256362dpl:AdministrativeExpenses2023-11-012023-11-0115256362core:NetGoodwill2023-11-012023-11-0115256362core:IntangibleAssetsOtherThanGoodwill2023-11-012023-11-0115256362dpl:GroupUndertakings2023-11-012023-11-0115256362dpl:ParticipatingInterests2023-11-012023-11-0115256362dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-012023-11-0115256362core:ListedExchangeTraded2023-11-012023-11-0115256362dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-012023-11-0115256362core:UnlistedNon-exchangeTraded2023-11-012023-11-0115256362core:NetGoodwill2024-11-3015256362core:IntangibleAssetsOtherThanGoodwill2024-11-3015256362core:LandBuildings2024-11-3015256362core:PlantMachinery2024-11-3015256362core:Vehicles2024-11-3015256362core:FurnitureFittings2024-11-3015256362core:OfficeEquipment2024-11-3015256362core:AfterOneYear2024-11-3015256362core:WithinOneYear2024-11-3015256362core:ListedExchangeTraded2024-11-3015256362core:UnlistedNon-exchangeTraded2024-11-3015256362core:ShareCapital2024-11-3015256362core:SharePremium2024-11-3015256362core:RevaluationReserve2024-11-3015256362core:OtherReservesSubtotal2024-11-3015256362core:RetainedEarningsAccumulatedLosses2024-11-3015256362core:NetGoodwill2023-11-0115256362core:IntangibleAssetsOtherThanGoodwill2023-11-0115256362core:LandBuildings2023-11-0115256362core:PlantMachinery2023-11-0115256362core:Vehicles2023-11-0115256362core:FurnitureFittings2023-11-0115256362core:OfficeEquipment2023-11-0115256362core:AfterOneYear2023-11-0115256362core:WithinOneYear2023-11-0115256362core:ListedExchangeTraded2023-11-0115256362core:UnlistedNon-exchangeTraded2023-11-0115256362core:ShareCapital2023-11-0115256362core:SharePremium2023-11-0115256362core:RevaluationReserve2023-11-0115256362core:OtherReservesSubtotal2023-11-0115256362core:RetainedEarningsAccumulatedLosses2023-11-0115256362core:NetGoodwill2023-10-3115256362core:IntangibleAssetsOtherThanGoodwill2023-10-3115256362core:LandBuildings2023-10-3115256362core:PlantMachinery2023-10-3115256362core:Vehicles2023-10-3115256362core:FurnitureFittings2023-10-3115256362core:OfficeEquipment2023-10-3115256362core:AfterOneYear2023-10-3115256362core:WithinOneYear2023-10-3115256362core:ListedExchangeTraded2023-10-3115256362core:UnlistedNon-exchangeTraded2023-10-3115256362core:ShareCapital2023-10-3115256362core:SharePremium2023-10-3115256362core:RevaluationReserve2023-10-3115256362core:OtherReservesSubtotal2023-10-3115256362core:RetainedEarningsAccumulatedLosses2023-10-3115256362core:AfterOneYear2023-11-022024-11-3015256362core:WithinOneYear2023-11-022024-11-3015256362core:Non-currentFinancialInstrumentscore:CostValuation2023-11-022024-11-3015256362core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-022024-11-3015256362core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-022024-11-3015256362core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-022024-11-3015256362core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-022024-11-3015256362core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-022024-11-3015256362core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-022024-11-3015256362core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-022024-11-3015256362core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-022024-11-3015256362core:Non-currentFinancialInstrumentscore:CostValuation2024-11-3015256362core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-3015256362core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-3015256362core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-3015256362core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-3015256362core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-3015256362core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-3015256362core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-3015256362core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-3015256362core:Non-currentFinancialInstrumentscore:CostValuation2023-11-0115256362core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-0115256362core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-0115256362core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-0115256362core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-0115256362core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-0115256362core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-0115256362core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-0115256362core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-0115256362bus:Director12023-11-022024-11-30

SPIKEX NEURAL TECHNOLOGIES LIMITED

Registered Number
15256362
(England and Wales)

Unaudited Financial Statements for the Period ended
30 November 2024

SPIKEX NEURAL TECHNOLOGIES LIMITED
Company Information
for the period from 2 November 2023 to 30 November 2024

Director

CHEN, Luhui

Registered Address

17 Shelton St
London
WC2H 9JN

Registered Number

15256362 (England and Wales)
SPIKEX NEURAL TECHNOLOGIES LIMITED
Statement of Financial Position
30 November 2024

Notes

2024

£

£

Current assets
Cash at bank and on hand377,840
377,840
Creditors amounts falling due within one year4(5,520)
Net current assets (liabilities)372,320
Total assets less current liabilities372,320
Net assets372,320
Capital and reserves
Called up share capital105
Share premium377,995
Profit and loss account(5,780)
Shareholders' funds372,320
The financial statements were approved and authorised for issue by the Director on 29 October 2025, and are signed on its behalf by:
CHEN, Luhui
Director
Registered Company No. 15256362
SPIKEX NEURAL TECHNOLOGIES LIMITED
Notes to the Financial Statements
for the period ended 30 November 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A, as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

2024
Average number of employees during the year1
3.Debtors: amounts due within one year
4.Creditors: amounts due within one year

2024

£
Accrued liabilities and deferred income5,520
Total5,520